Trial Profile
A non-interventional, prospective, observational study of interferon beta-1a in multiple sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2016
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms RebiSTART
- 20 Sep 2016 New trial record